The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants

EuroIntervention 2018;13:1655-1661 published online May 2017. DOI: 10.4244/EIJ-D-17-00006

1. Pediatric Cardiology and Intensive Care Medicine, Georg-August University, Göttingen, Germany; 2. The Queen Silvia Children’s Hospital, Gothenburg, Sweden; 3. Department of Pediatric Cardiology, Deutsches Herzzentrum, Berlin, Germany; 4. CARAG AG, Baar

Aims: The aim of this study was to evaluate local biological responses to the partially bioresorbable non-metal frame Carag bioresorbable septal occluder system in an experimental setting

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Design and principle of operation of the HeartMate PHP (percutaneous heart pump)